Paper348261
Bromocriptine in Parkinsonism.
Pearce I and 1 other. Br Med J, 1978. Cited by 31 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bromocriptine in Parkinsonism. Papers, record 348261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/348261
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bromocriptine | Major topic |
| Parkinson Disease | Major topic |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Humans | |
| Levodopa | |
| Psychoses, Substance-Induced |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 330,825 | Comparison of the effects of bromocriptine and levodopa in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/330825 | PubMed |
| 2 | 912,157 | Bromocriptine. | Br J Hosp Med | 1977 | https://conductscience.org/library/papers/912157 | PubMed |
| 3 | 1,036,999 | Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. | J Neurol Neurosurg Psychiatry | 1976 | https://conductscience.org/library/papers/1036999 | PubMed |
| 4 | 989,885 | Treatment of parkinson's disease with bromocriptine. | N Engl J Med | 1976 | https://conductscience.org/library/papers/989885 | PubMed |
| 5 | 4,126,558 | Sustained levodopa therapy in parkinsonism. | Lancet | 1973 | https://conductscience.org/library/papers/4126558 | PubMed |
| 6 | 48,873 | Letter: Parkinsonism and dementia: effects of levodopa. | Lancet | 1975 | https://conductscience.org/library/papers/48873 | PubMed |
| 7 | 59,850 | Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. | Lancet | 1976 | https://conductscience.org/library/papers/59850 | PubMed |
| 8 | 53,655 | Bromocriptine therapy in acromegaly. | Lancet | 1975 | https://conductscience.org/library/papers/53655 | PubMed |
| 9 | 4,945,017 | Current concepts of Parkinsonism. | Postgrad Med J | 1971 | https://conductscience.org/library/papers/4945017 | PubMed |
| 10 | 812,004 | On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. | Neurology | 1975 | https://conductscience.org/library/papers/812004 | PubMed |
| 11 | 773,080 | Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial. | Acta Neurol Scand | 1976 | https://conductscience.org/library/papers/773080 | PubMed |
| 12 | 943,193 | Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. | Br J Pharmacol | 1976 | https://conductscience.org/library/papers/943193 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,428,799 | Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7428799 | PubMed |
| 6,882,030 | Gas-liquid chromatographic analysis of synovial fluid: volatile short-chain fatty acids in septic arthritis. | Ann Rheum Dis | 1983 | https://conductscience.org/library/papers/6882030 | PubMed |
| 6,861,794 | Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism. | Eur J Drug Metab Pharmacokinet | 1983 | https://conductscience.org/library/papers/6861794 | PubMed |
| 6,188,812 | Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment. | J Neurol | 1982 | https://conductscience.org/library/papers/6188812 | PubMed |
| 6,180,142 | Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085. | J Neurol | 1982 | https://conductscience.org/library/papers/6180142 | PubMed |
| 3,998,746 | Low-dose bromocriptine in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1985 | https://conductscience.org/library/papers/3998746 | PubMed |
| 2,651,567 | Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group. | J Neurol Neurosurg Psychiatry | 1989 | https://conductscience.org/library/papers/2651567 | PubMed |
| 477,712 | Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/477712 | PubMed |
| 365,210 | Dopamine agonists for negative symptoms in schizophrenia. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/365210 | PubMed |
| 32,952 | Aetiology and natural history of Parkinson's disease. | Br Med J | 1978 | https://conductscience.org/library/papers/32952 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/348261
GET https://conductscience.org/api/papers/v1/348261/authors